Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 8/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.34 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14734042 | 0.90 | L3MBTL1 (0.47) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL14734041 | 0.81 | PPARG (0.47) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL14733286 | 0.81 | L3MBTL1 (0.42) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL14734044 | 0.79 | LMNA (0.50) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL14734043 | 0.79 | LMNA (0.50) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL29227996 | 0.75 | TSHR (0.56) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL12043029 | 0.74 | ALDH1A1 (0.48) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL12043040 | 0.74 | ALDH1A1 (0.48) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL16480631 | 0.74 | PPARG (0.46) | L3MBTL1TSHRALDH1A1LMNAPPARG | |
| SCHEMBL14733285 | 0.72 | LMNA (0.47) | L3MBTL1TSHRLMNAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053590-A1 | LUBRICITY IMPROVER | ELOVL1, ELOVL5, FASN | L3MBTL1 3484/4885TSHR 4404/4885ALDH1A1 821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.